Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI filing briefs

Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

SHPH 8-K filings, explained

Every material Form 8-K Shuttle Pharmaceuticals Holdings, Inc. has filed with the SEC since November 06, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs on record1since Nov 06, 2026
Latest filingNov 06, 2026other
High impact (4-5)0of 1 brief
ToneNeutral1

2026

Nov 6, 5:25 PM ET

Shuttle Pharmaceuticals replaces Forvis Mazars with Bush & Associates as auditor

Neutral other 4.01

Shuttle Pharmaceuticals Holdings dismissed Forvis Mazars, LLP as its independent registered public accounting firm and engaged Bush & Associates CPA LLC on November 2, 2026. Bush & Associates will audit the fiscal year ending December 31, 2026, and review interim financial statements through September 30, 2027. The filing states no disagreements or reportable events with the former auditor.

  • Forvis Mazars dismissal was approved by the Audit Committee and full Board, effective after the Form 10-Q for the quarter ended September 30, 2026, as previously reported October 21, 2026.
  • Bush & Associates CPA LLC was engaged on November 2, 2026, under an engagement letter dated October 19, 2026.
  • Bush & Associates will audit fiscal 2026 and review interim quarters ending March 31, June 30 and September 30, 2027.
  • The company states there were no consultations with Bush & Associates on accounting matters and no disagreements or reportable events in fiscal 2024, fiscal 2025 or the interim period through November 2, 2026.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Shuttle Pharmaceuticals Holdings, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →